Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06366672
EARLY_PHASE1

Evaluating the Human Immune Response to the JYNNEOS Vaccine

Sponsor: Washington University School of Medicine

View on ClinicalTrials.gov

Summary

This study is designed to evaluate the magnitude and duration of the human adaptive immune response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine in the blood, lung mucosa, skin and bone marrow.

Official title: Evaluating the Durability of the Human Immune Response to the JYNNEOS Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2024-06-10

Completion Date

2026-12

Last Updated

2025-10-16

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) suspension for subcutaneous injection

live, nonreplicating vaccine delivered according to the FDA approved package insert

PROCEDURE

Phlebotomy

Research blood draw

PROCEDURE

Research bronchoscopy

Outpatient research bronchoscopy with bronchoalveolar lavage and endobronchial biopsy performed with conscious sedation.

PROCEDURE

Skin punch biopsy

Skin punch biopsy performed with topical anesthesia.

PROCEDURE

Bone marrow aspiration

Bone marrow aspiration performed with local anesthesia.

Locations (1)

Washington University in Saint Louis School of Medicine Emergency Care and Research Core

St Louis, Missouri, United States